Stretch Marks Treatment Market Is Likely To Up Demand At A USD 3.9 Billion By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report  Stretch Marks Treatment Market Size, Share & Trends Analysis Report By Treatment (Topical Products, Laser, Microdermabrasion), By Region, And Segment Forecasts, 2019 – 2026

The global stretch marks treatment market size is projected to reach USD 3.9 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.04% during the forecast period. Increasing awareness among women regarding the treating stretch marks caused during pregnancy is significantly driving the growth. Also, the growing prevalence of stretch marks in adolescents and teenagers is predicted to fuel the demand for their treatment.

High number of obese population in North America is majorly driving the market in the region. This is an opportunity for the players for expanding their consumer target and strengthening their market presence. Moreover, the increasing number of key players in the region is another factor driving the competition, thereby positively influencing the stretch marks treatment market.

Growing number of online portals for the sale of topical products for treating stretch marks is another opportunity for the players. The key players can thus, increase their sale through these online portals and expand their product portfolio. Moreover, consumer preference for topical products is augmenting its demand, thus affecting the market.

Rise in the launch of new products and adoption of growth strategies, such as partnerships and innovations are trending in the market. Growing Asia Pacific economies and rise in spending power of consumers in these regions is also influencing the market growth positively.

Access Research Report of Stretch Marks Treatment Market www.grandviewresearch.com/industry-analysis/stretch-marks-treatment-market

Further key findings from the report suggest:

  • Topical products is the leading segment owing to increasing cases of stretch marks caused due to pregnancy, obesity, history of delivering twins or large babies, pale skin, sudden weight loss or gain, and others
  • Creams segment is expected to grow considerably during the forecast period owing to increased sales due to high demand, rise in disposable income of consumers, and increased promotion of creams
  • Fractional laser segment is expected to grow substantially over the forecast period, since these products improve the skin tone, reduce the common signs of aging, and enhance the skin texture
  • Pulse-dye lasers domain is also growing significantly due to completely safety assurance for the patients, no need of anesthesia since the machine produces cold spray just before pulsing, eliminating the pain sensation
  • Asia Pacific is the dominant segment in the stretch marks treatment market owing to increasing disposable income, changing lifestyle, and emerging online shopping portals

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global stretch marks treatment market on the basis of treatment and region:

Stretch Marks Treatment Outlook (Revenue, USD Million, 2015 – 2026)

  • Topical Products
    • Creams
    • Oils & Serum
    • Lotion
  • Laser
    • Fractional Laser
    • Pulse-Dye Laser
    • Others
  • Microdermabrasion

Stretch Marks Treatment Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Stretch Marks Treatment Market www.grandviewresearch.com/press-release/global-stretch-marks-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Nephrostomy Devices Market Accounted To Reach USD 1.71 Billion By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report Nephrostomy Devices Market Size, Share & Trends Analysis Report By Product (Guidewires, Nephrostomy Catheters), By End Use (ASCs, Hospitals), By Region, And Segment Forecasts, 2019 – 2026

The global nephrostomy devices market size is anticipated to reach USD 1.71 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. Increasing awareness about nephrostomy devices among physicians and rising cases of kidney stone disease are driving the market. Increasing prevalence of ovarian, bladder, and prostate cancers and improving healthcare infrastructure in the developing economies are also among the key factors fueling the market growth.

North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.

Access Research Report of Nephrostomy Devices Market www.grandviewresearch.com/industry-analysis/nephrostomy-devices-market

Further key findings from the study suggest:

  • Guidewires segment led the global nephrostomy devices market in 2018 and is anticipated to expand further at the highest CAGR from 2019 to 2026
  • The segment growth is attributed to rising cases of kidney and urine related disorders, and preference for guidewires as they are less invasive
  • The hospital segment dominated the market in 2018. Percutaneous nephrostomy are majorly performed in the hospitals as compared to the emergency clinics, which drives the segment growth
  • ASCs segment is anticipated to register the highest CAGR as nephrostomy devices are widely used by ASCs due to their benefits, such as significant cost saving and personalized services
  • North America leads the market due to high prevalence of target diseases, availability of skilled surgeons, presence of well-established healthcare sector, and quick adoption of advanced medical tools
  • Key companies in the market focus on strategies, such as innovations in the existing products, introduction of new products, and mergers and acquisitions to strengthen their presence in the industry

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global nephrostomy devices market on the basis of product, end use, and region:

Nephrostomy Devices Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Guidewires
  • Drainage Tubes
  • Nephrostomy Catheters
  • Sheath Dilators
  • Others

Nephrostomy Devices End Use Outlook (Revenue, USD Million, 2015 – 2026)

  • Hospitals
  • Emergency Clinics
  • Ambulatory Surgical Centers (ASCs)

Nephrostomy Devices Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Nephrostomy Devices Market www.grandviewresearch.com/press-release/global-nephrostomy-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

 

 

 

Emergency Medical Services Products Market Estimated To Reach USD 34.15 Billion By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report Emergency Medical Services Products Market Size, Share & Trends Analysis Report By Product (Patient Monitoring Systems, Life Support & Emergency Resuscitation), By Region, And Segment Forecasts, 2019 – 2026

The global emergency medical services products market size is expected to reach USD 34.15 billion by 2026 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing demand for emergency care and increasing healthcare expenditure across the globe are the key factors driving the market. Increasing cases of trauma, caused by road accidents, natural disasters, and sports and other injuries, is also one of the key growth-driving factors for the market.

For instance, as per the Centers for Disease Control and Prevention (CDC), traumatic brain injury is the major cause of disability and death in U.S., accounting for 30.0% of all injury-related deaths. Emergency medical services (EMS) and trauma centers work closely to initiate the pre-hospital treatment process. In U.S., the government introduced Emergency Medical Treatment and Labor Act (EMTALA) in 1986. As per the law, anyone going to the emergency department has to be treated and stabilized, irrespective of their ability to pay or their insurance status.

Such laws are improving the accessibility of emergency care. In addition, rising healthcare expenditure across the globe is likely to improve the quality of emergency medical services. Such factors are expected to boost the EMS products market over the forecast period. Moreover, associations, such as American Trauma Society (ATS), offer courses and training for preventing injuries, which drives the demand for EMS products. ATS offers a two-day course developed by seasoned injury prevention professionals across the country.

Access Research Report of Emergency Medical Services Products Market www.grandviewresearch.com/industry-analysis/emergency-medical-services-ems-products-market

Further key findings from the study suggest:

  • In terms of revenue, life support & emergency resuscitation systems led the EMS products market in 2018 and will continue its dominance throughout the forecast years
  • Increasing cases of trauma and demand for emergency care contributes to the growth of the life support & emergency resuscitation systems segment
  • Defibrillators segment is expected to witness the fastest growth over the forecast period owing to the rise in number of Cardiovascular Diseases (CVDs).
  • Asia Pacific is expected to witness the fastest CAGR from 2019 to 2026 owing to rapid development of healthcare infrastructure and rising number of start-ups in this region
  • Prominent key companies in the market are Bound Tree Medical; McKesson Medical-Surgical, Inc.; Stryker Corp.; and Medline Industries, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global EMS products market on the basis of product and region:

EMS Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Life Support & Emergency Resuscitation
    • Defibrillators
    • Endotracheal Tubes
    • Ventilators
    • Resuscitators
    • Laryngoscopes
  • Patient Monitoring Systems
  • Wound Care Consumables
    • Dressings & Bandages
    • Sutures & Staples
    • Others
    • Musculoskeletal
    • Others
  • Patient Handling Equipment
    • Medical Beds
    • Wheelchairs and Scooters
    • Other Equipment
  • Infection Control Supplies
    • Disinfectant and Cleaning Agents
    • Personal Protection Equipment
    • Others
  • Other EMS Products

EMS Products Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MEA

Access Press Release of Emergency Medical Services Products Market www.grandviewresearch.com/press-release/global-emergency-medical-services-ems-products-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

mHealth Apps Market Expected To Grow With USD 236.0 Billion By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report mHealth Apps Market Size, Share & Trends Analysis Report By Type (Fitness, Lifestyle Management, Nutrition & Diet, Women’s Health, Medication Adherence, Healthcare Providers/Payers), And Segment Forecasts, 2019 – 2026

The global mHealth apps market size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 44.7% during the forecast period. The market is majorly driven by increasing adoption of advanced technologies in healthcare facilities and the need to reduce long waiting periods to access healthcare facilities from specialists.Availability of mobile applications for users is witnessing a rapid growth, especially healthcare apps that assist consumers in self-management of disease, wellness, and chronic conditions. This increased role of patients coupled with the rising importance in staying updated and informed about their own healthcare decisions, contributing to the rise in adoption of mHealth apps globally.

Healthcare industry has been transitioning towards a value-based care model with mHealth becoming a widespread trend owing to the advent of technologies such as remote monitoring, electronic medical record, and other communication platforms. The increasing prevalence of disorders, such as diabetes, hypertension, cancer, and obesity along with the growing awareness about wellness and other preventive measures diseases among patients is expected to boost the mHealth market growth.

mHealth leverages from the 4Ps: personalized, predictive, participatory, and preventive measures for care delivery to provide optimal care to users. Moreover, rising penetration of smartphones, and other electronic devices, especially, in low- and middle-income countries and increasing focus on the use of mobile technology to manage care delivery is anticipated to benefit the market.

Access Research Report of MHealth Apps Market www.grandviewresearch.com/industry-analysis/mhealth-app-market

Further key findings from the report suggest:

  • Rapid growth in chronic diseases along with the rise in the number of app users is accountable for the mHealth apps market growth
  • The types of mHealth apps include fitness, lifestyle management, nutrition and diet, women’s health, medication adherence, healthcare providers, and disease management. Of these, the fitness category accounted for the majority of segment share in 2018
  • mHealth app vendors are focusing their attention on women’s health, diet, and medication reminders. According to Wired, a mobile advertising and analytics platform, women are more inclined toward tracking their health than men
  • Physicians are increasingly recommending the use of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps
  • North America led the mhealth applications market in 2018 in terms of revenue share pertaining to the technological advancements and presence of major players in the region
  • Some of the key players are Johnson & Johnson; Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd; Novartis AG; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer; and Sanofi

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global mHealth apps market based on type and region:

mHealth Apps Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Fitness
  • Lifestyle Management
  • Nutrition & Diet
  • Women’s Health
  • Medication Adherence
  • Healthcare Providers/ Payors
  • Disease Management
  • Others

mHealth Apps Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of MHealth Apps Market www.grandviewresearch.com/press-release/global-mhealth-app-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Dental Lasers Market Expected To Fuel Industry Growth With USD 101.3 Million By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report Dental Lasers Market Size, Share & Trends Analysis Report By Product (Soft Tissue, All Tissue), By Application (Conservative Dentistry, Endodontic Treatment), By End Use (Hospitals, Dental Clinics), And Segment Forecasts, 2019 – 2026

The global dental lasers market size is expected to reach USD 101.3 million by 2026, according to a new report by Grand View Research Inc. It is projected to register a CAGR of 6.5% during the forecast period. Rising application of dental lasers for the treatment of dental diseases and procedures, such as cavity preparation, dentinal hypersensitivity, restorative removal, growth modulation, and caries prevention, is contributing to the growth. In addition, increasing adoption in hyperplastic tissue removal, wound healing, photostimulation of herpetic lesions, and photodynamic therapy for malignancies is anticipated to fuel the demand.

Advantages such as high efficiency, less bleeding, better control of soft tissue, and comfortable treatment are anticipated to further fuel the demand for dental lasers. Additionally, many insurance policies cover the usage of dental lasers for conservative soft tissue, therefore fueling market growth. Technological advancements are predicted to offer lucrative opportunities in the forthcoming years. Growing use of lasers in dentistry domain coupled with increasing acceptance of devices with novel technologies by dental surgeons are few emerging trends witnessed in the market.

Access Research Report of Dental Lasers Market www.grandviewresearch.com/industry-analysis/dental-lasers-market

Further key findings from the report suggest:

  • Soft tissue is the fastest growing segment owing to the rising number of soft tissue disorders, such as periodontal disorders and gingivitis. Diode lasers are majorly used in soft tissues procedures, driving the segment growth
  • Oral surgery segment is expected to witness lucrative growth in the next seven years owing to the rise in the number of patients demanding bone and gum tissue restructuring. Rising awareness regarding oral hygiene is expected to further impel the growth
  • Hospital segment is expected to expand at a CAGR of 5.7% by 2026 owing to improving healthcare facilities in the emerging economies and well-established medical settings in the developed nations
  • North America dental laser market has been estimated to be the largest owing to rise in awareness regarding oral hygiene, increasing incidence of dental diseases such as gingivitis, periodontics, and caries
  • Key players of dental laser market include Biolase, Inc.; AMD LASERS; FOTONA D.D.; Ivoclar Vivadent AG; Danaher; Dentsply Sirona Inc.; Syneron Dental; ZOLAR Technology & Mfg Co. Inc.; THE YOSHIDA DENTAL MFG. CO., LTD.; and Convergent Dental

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global dental laser market on the basis of product, application, end use, and region:

Dental Lasers Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Soft Tissue
  • All Tissue
  • Dental Welding Lasers

Dental Lasers Application Outlook (Revenue, USD Million, 2015 – 2026)

  • Conservative Dentistry
  • Endodontic Treatment
  • Oral Surgery
  • Implantology
  • Peri-Implantitis
  • Periodontics
  • Tooth Whitening.

Dental Lasers End Use Outlook (Revenue, USD Million, 2015 – 2026)

  • Hospitals
  • Dental Clinics

Dental Lasers Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Dental Lasers Market www.grandviewresearch.com/press-release/global-dental-laser-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Ophthalmic Knives Market Poised To Augment The Industry At $ 2.4 Billion By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report Ophthalmic Knives Market Size, Share & Trends Analysis Report By Design (Straight, Crescent, Slit, MVR, Stab), By Product (Reusable, Single-use), By End User (Hospitals, ASCs, Clinics), And Segment Forecasts, 2019 – 2026

The global ophthalmic knives market size is expected to reach USD 2.4 Billion by 2026, as per a new report by Grand View Research Inc. It is projected to register a CAGR of 4.9% during the forecast period. Introduction of advanced knives and rising incidence of age related ophthalmic diseases are some of the major factors driving the growth.

Increasing overall life expectancy and rising geriatric population is expected to cause steep increase in age related ophthalmic disorders. Along with these, incidence of lifestyle associated ophthalmic devices including myopia and hypermetropia are expected showcase significant growth during the forecast period. Most of these ophthalmic conditions cannot be treated by drugs. Increasing number of ophthalmic surgeries are expected to boost the market during forecast period.

High competition and introduction of local players are the factors encouraging market players to introduce advanced knives at affordable prices. Major players are focusing on developing innovative manufacturing techniques along with advanced raw materials to reduce the device price.

Incorporation of new reimbursement policies in developed countries along with growing efforts of non-profit organizations to increase awareness about ophthalmic conditions and to provide affordable/free ophthalmic procedures in rural regions are the factors expected to boost the number of ophthalmic surgeries.

Access Research Report of Ophthalmic Knives Market www.grandviewresearch.com/industry-analysis/ophthalmic-knives-market

Further key findings from the report suggest:

  • North America captured the largest ophthalmic knife industry share in 2018 owing to favorable reimbursement policies, presence of major market players, and rise in geriatric population
  • Straight knives segment is anticipated to expand at a CAGR of 4.10% during the forecast period owing to fine design, durability, and sharpness of the knives
  • Slit knives segment is also expected to register lucrative CAGR in near future owing to extensive use for entry in anterior chamber/phaco stab incision (single bevel) in eye-related surgeries
  • Single-use/disposable knives segment is expected to witness significant growth over the forecast period due to features such as safety and affordability
  • The key players profiled in the ophthalmic knife market comprise Alcon, Inc.; Hoya Corporation; Essilor; Topcon Corporation; Hai Laboratories, Inc.; Bausch and Lomb Incorporated; MANI Inc.; Seiko Optical Products Co., Ltd.; Nidek Co., Ltd.; Ziemer Group; Alltion; and DGH Technology

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global ophthalmic knife market on the basis of design, product, end user, and region:

Ophthalmic Knives Design Outlook (Revenue, USD Million, 2015 – 2026)

  • Straight Knives
  • Crescent Knives
  • Slit Knives
  • MVR Knives
  • Stab Knives
  • Others

Ophthalmic Knives Ophthalmic Knives Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Reusable
  • Single-use

Ophthalmic Knives End Users Outlook (Revenue, USD Million, 2015 – 2026)

  • Hospitals
  • ASCs
  • Clinics

Ophthalmic Knives Region Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Ophthalmic Knives Market www.grandviewresearch.com/press-release/global-ophthalmic-knife-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

 

Spinal Cord Stimulation Devices Market Size To Hit USD 3.58 Billion By 2026 : Grand View Research Inc.

San Francisco, 31 July 2019: The Report Spinal Cord Stimulation Devices Market Size, Share & Trends Analysis Report By Application (Degenerative Disk Disease, CRPS), By Product (Rechargeable, Non-rechargeable), And Segment Forecasts, 2018 – 2026

The global spinal cord stimulation devices market size is anticipated to reach USD 3.58 billion by 2026 registering a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing incidence of failed back syndrome and complex regional pain syndrome is anticipated to boost the market growth. Failed back syndrome occurs as a chronic pain after spinal surgeries for back or leg pain. After spinal surgery, the pain gets reduced or the condition may get worst due to scar tissue which build up around the spinal nerve roots.

Spinal cord stimulation device is used to treat patients who failed to get the result from spinal surgeries, by blocking the pain before it reaches the brain. Thus, increasing number of patients suffering from chronic pain after surgeries is likely to augment the product demand over the forecast period. In addition, technological advancements are expected to fuel the market growth further. For instance, Medtronic’s Intellis is a smallest implantable spinal cord stimulator designed to overcome limitations with the current systems.

The high dose therapy of the device helps reduce the pain for the patients suffering from diseases, such as degenerative disk disease. Key companies are introducing technologically enhanced products to gain competitive advantage in the industry. For instance, in January 2019, Boston Scientific launched its Spectra WaveWriter spinal cord stimulator in Europe. It is used for the treatment of chronic pain through electrical impulses. This new system also allows physicians and patients to customize their therapy.

Access Research Report of Spinal Cord Stimulation Devices Market www.grandviewresearch.com/press-release/global-spinal-cord-stimulation-devices-market

Further key findings from the study suggest:

  • Rechargeable device segment led the global market in 2018 and is projected to expand further at the fastest CAGR from 2018 to 2026
  • This is attributed to the factors, such as new product launches by key companies and increasing number of patients suffering from neuropathic pain
  • Failed back syndrome was the dominant application segment in 2018 owing to high number of patients suffering from pain after spinal surgeries
  • North America led the global spinal cord stimulation devices market in 2018 owing to the increased incidence of post-laminectomy syndrome followed by chronic longstanding back pain

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global spinal cord stimulation devices market on the basis of product, application, and region:

Spinal Cord Stimulation Devices Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Rechargeable
  • Non-rechargeable

Spinal Cord Stimulation Devices Application Outlook (Revenue, USD Million, 2015 – 2026)

  • Failed Back Syndrome
  • Complex Regional Pain Syndrome
  • Degenerative Disk Disease
  • Unsuccessful Disk Surgery
  • Others

Spinal Cord Stimulation Devices Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Access Press Release of Spinal Cord Stimulation Devices Market www.grandviewresearch.com/press-release/global-spinal-cord-stimulation-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Anti-Acne Cosmetics Market Is Anticipated To Reach USD 3.88 Billion By 2026: Grand View Research Inc.

San Francisco, 31 July 2019: The Report Anti-Acne Cosmetics Market Size, Share & Trends Analysis Report By Product Type (Creams & Lotions, Mask, Cleansers & Toners), By End Use (Women, Men), And Segment Forecasts, 2019 – 2026

The global anti-acne cosmetics market size is expected to reach USD 3.88 billion by 2026 according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 8.2% during the forecast period. The high psychological burden associated with acne is mainly expected to drive the anti-acne cosmetics market. Moreover, easy availability of anti-acne products through several offline and online shops is also anticipated to drive the growth.

According to the America Academy of Dermatology, acne is one of the common skin disorders in U.S., affecting approximately 50 million individuals every year with nearly 85% individuals between the age group of 12 to 24 years suffering from minor acne. Thus, such high prevalence among adolescents and young adults is anticipated to fuel the market growth.

According to a study conducted by SkinStore, an average American women uses nearly 16 skin care products on her face daily and spends approximately USD 8 every day on facial cosmetics products to prevent acne, pigmentation, blemishes, dark circles, and wrinkles. Such beauty regimes are anticipated to propel the market growth.

According to a study by the University of Limerick, negative social stigma associated with acne reduces the quality of life of individuals, increases their psychological distress, and causes physical problems such as headaches, sleep disturbance, and gastrointestinal issues. Hence, the negative perceptions associated with acne is anticipated to increase the demand for anti-acne cosmetics.

Access Research Report of Anti-Acne Cosmetics Market www.grandviewresearch.com/industry-analysis/anti-acne-cosmetics-market

Further key findings from the report suggest:

  • Creams and lotions segment led the market in 2018 as acne cream is the first line of therapy for all types of acne and it also provides skin moisturization, thus reducing skin dryness caused by acne
  • The others segment is expected to expand at a rapid pace over the forecast period, due to the compatibility of these products with various skin types and their lightness on skin as compared to creams and lotions
  • Women segment held the dominant market share in 2018 and is expected to grow at a remunerative rate during the forecast period owing to high prevalence and awareness regarding the same
  • Asia Pacific is anticipated to grow significantly over the forecast period due to increasing disposable income in developing countries as well as increasing population leading an unhealthy lifestyle
  • Some of the key players in the anti-acne cosmetics market are Neutrogena; Clinique; Murad; Kose; LaRochPosay; Mentholatum; L’Oréal; Proactiv; and Vichy

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global anti-acne cosmetics market on the basis of product, end use, and region:

Anti-acne Cosmetics Product Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Mask
  • Creams & Lotions
  • Cleansers & Toners
  • Others

Anti-acne Cosmetics End Use Outlook (Revenue, USD Million, 2015 – 2026)

  • Women
  • Men

Anti-acne Cosmetics Region Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Anti-Acne Cosmetics Market www.grandviewresearch.com/press-release/global-anti-acne-cosmetics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Magnetic Resonance Imaging Market Progressing At A CAGR Of 5.3% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.

San Francisco, 30 July 2019: The Report Magnetic Resonance Imaging Market Size, Share & Trends Analysis Report By Architecture (Open, Closed), By Field Strength (Near, Mid, Far), By Application, By End Use, And Segment Forecasts, 2019 – 2026

The global MRI market size is expected to reach an approximate value of USD 5.8 billion by 2026, according to a report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.3% during the forecast period. Constant introduction of advanced disease diagnostic technologies is primarily boosting the growth. Rapid growth of MRI sector is attributed to the rising prevalence of chronic diseases which require early diagnosis and timely treatment to prevent late stage complications. Also, rising number of road accidents leading to injuries and complications are augmenting the demand for this modality. The musculoskeletal and spine injuries also demand for these systems for better diagnosis using high-resolution scanning technique.

On the other hand, high cost and requirement of qualified professional to operate the device are some of the major factors challenging the growth of the MRI market. Moreover, prolonged life span of these devices is resulting in delayed repeat purchase and thereby hindering the market growth.

Market players are adopting various strategies such as collaborations and mergers and acquisitions to remain competent. For instance, Aurora Imaging Technology signed a distribution agreement with Sumec Group Corporation. Under the terms of agreement, Sumec Corporation is distributing Aurora Imaging Technology’s MRI system in China. The agreement provided a platform for both the companies to expand their diagnostics and screening market for breast scans using Aurora MRI system in China.

Access Research Report of Magnetic Resonance Imaging Market www.grandviewresearch.com/industry-analysis/magnetic-resonance-imaging-market

Further key findings from the report suggest:

  • Closed system segment held the largest market share in 2018. Whereas open system is anticipated to be the fastest growing segment during the forecast period.
  • MRI for neural and brain disorders led the magnetic resonance imaging market owing to the lack of lternate scanning tool
  • High field MRI segment which includes 1.5T to 7T MRI machines, is expected to showcase a significant CAGR in developed regions during the forecast period
  • Ambulatory surgical centers are expected to exhibit the highest CAGR during the forecast period owing to government initiatives to improve primary care
  • In 2018, North America led with the largest revenue share owing to continuous research and high adoption of advanced techniques. Whereas Asia Pacific is anticipated to showcase the fastest CAGR from 2019 to 2026
  • Rapidly growing medical tourism industry coupled with growing disposable income of India, and China are some of the factors that are expected to drive the growth
  • Major players competing in the industry include but are not limited to Siemens AG; Koninklijke Philips N.V.; GE Healthcare; and Hitachi Medical Systems

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global MRI market based on architecture, field strength, application, and end use, and region:

Magnetic Imaging Resonance (MRI) Architecture Outlook (Revenue, USD Million, 2015 – 2026)

  • Closed System
  • Open System

Magnetic Imaging Resonance (MRI) Field Strength Outlook (Revenue, USD Million, 2015 – 2026)

  • Low Field Strength
  • Mid Field Strength
  • High Field Strength

Magnetic Imaging Resonance (MRI) Application Outlook (Revenue, USD Million, 2015 – 2026)

  • Brain and Neurological
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Spine and musculoskeletal
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Vascular
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Abdomen
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Cardiac
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Breast
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Other
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength

Magnetic Imaging Resonance (MRI) End Use Outlook (Revenue, USD Million, 2015 -2026)

  • Hospitals
  • Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Magnetic Imaging Resonance (MRI) Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Magnetic Resonance Imaging Market www.grandviewresearch.com/press-release/global-magnetic-resonance-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Epigenetics Market Value To Reach USD 22.05 Billion By 2025 : Grand View Research Inc.

San Francisco, 30 July 2019: The Report Epigenetics Market Size, Share & Trends Analysis Report By Technology, By Application (Oncology, Non-oncology), By Product (Reagents, Instruments, Enzyme, Kits, Services), And Segment Forecasts, 2018 – 2025

The global epigenetics market size is expected to reach USD 22.05 billion by 2025, according to a new study by Grand View Research, Inc., progressing at a CAGR of 19.7% during the forecast period. Growing prevalence of cancer and other diseases worldwide with epigenetic modification base is expected to drive the market during the forecast period.

Diagnostic companies are coming up with new products such as antibodies specific for detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is estimated to attract pharmaceutical companies to collaborate for development of therapeutic drugs, which will work in favor of the market.

Presence of pipeline drugs and their expected commercialization is anticipated to boost the growth of the market. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by FDA for use in combination with Folfiri for treatment of patients with metastatic colorectal cancer.

Technology advancements in the epigenetics industry are majorly focusing on detection of methylation markers related to cancer development. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene.

Access Research Report of Epigenetics Market www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the study suggest:

  • On the basis of product, reagents held the largest share in the market in 2017. They are projected to amount to approximately USD 7.06 billion by 2025 owing to increasing R&D activities in the field of epigenetics
  • The kits segment is expected to post a CAGR of over 20.0% due to need for rapid and accurate detection techniques
  • DNA methylation, on the basis of technology, held the leading revenue share in the market in 2017, accounting for just over 47.0%. Rapid adoption of advanced techniques such as methylation sensitive PCR (MSP) to improve diagnostics efficiency is poised to bolster the growth of the segment
  • North America commanded the leading position in the global arena with a share of 40.0% in 2017. The growth of the regional market can be attributed to increasing prevalence of cancer and growing collaborations between large pharmaceutical firms for development of improved therapeutics
  • Asia Pacific is estimated to register a noteworthy CAGR of 22.1% during the forecast period owing to presence of large target population coupled with high unmet clinical needs
  • Some of the major players of epigenetics market are Illumina; Abcam; Diagenode; Thermo Fisher Scientific; Merck; Zymo research; Qiagen; CellCentric Ltd; Chroma Therapeutics Ltd; Eisai Co. Ltd; Novartis International AG; Oncolys Biopharma Inc.; Syndax Pharmaceuticals, Inc.; Valirx Plc; and Sigma-Aldrich Corporation
  • Extensive R&D initiatives for development of novel drugs and presence of strong product pipeline are expected to further boost market growth over the forecast period.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Reagents
  • Kits
    • ChIP sequencing kit
    • Whole Genomic Amplification Kit
    • Bisulfite Conversion kit
    • RNA sequencing kit
    • Others
  • Instruments
  • Enzymes
  • Services

Epigenetics Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large noncoding RNA
  • MicroRNA Modification
  • Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases

Epigenetics Regional Outlook(Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Access Press Release of Epigenetics Market www.grandviewresearch.com/press-release/global-epigenetics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

 

Design a site like this with WordPress.com
Get started